Private equity remains active in healthcare, including in the ASC ecosystem, but the strategy is shifting. Rather than building standalone ASC platforms, firms are increasingly pairing ASC investments ...

PE ownership of ophthalmology practices has reshaped physician opportunities and patient care. Will things change with ...

For 40 years, private equity enjoyed extraordinary returns thanks to falling rates and abundant credit. That's changed. What ...

Opinion: Private equity firms that invest in health care should structure deals and operations for CPOM compliance, ...

Retail investors are increasingly eager to access private equity (“PE”), drawn by the promise of higher returns and diversification. With public markets dominated by a narrow set of tech-driven ...

Recent reports of a variety of law firms engaging in discussions with private equity investors have spawned speculation about the firms’ motivations for such discussions with unseasoned observers ...

As the ad agency model struggles to evolve to meet client demands and navigate AI’s impact, ad agencies have been searching for partners to help themselves scale, thrive or in some cases just survive.

Hospice is a realm of medicine concerned not with curing patients, but helping them end their lives with comfort, meaning and dignity. But, with a major transaction under consideration, Oregon ...

Jeff Bartel is chairman and managing director of Hamptons Group, a private investment and strategic advisory firm headquartered in Miami. The adoption of AI in private equity experienced rapid growth ...

Over the past 15 years, the meaning of the term "sponsor" in the private equity context has evolved to include several alternatives to the standard committed private equity fund model. These ...